ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
13,719,592
Share change
+3,454,128
Total reported value
$65,153,889
Put/Call ratio
170%
Price per share
$4.75
Number of holders
82
Value change
+$14,536,188
Number of buys
49
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q2 2021

As of 30 Jun 2021, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,719,592 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, NORGES BANK, Parkman Healthcare Partners LLC, ACT Capital Management, LLC, and BRIGHTON JONES LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.